|Bid||11.58 x 1100|
|Ask||11.59 x 1200|
|Day's range||10.70 - 12.19|
|52-week range||3.71 - 32.88|
|Beta (5Y monthly)||3.35|
|PE ratio (TTM)||51.26|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It's easy to be down on a stock like Aurora Cannabis (NYSE: ACB). The company continues to issue more shares, and is struggling to grow and stay out of the red. Below, I'll take a look at whether this is the start of a new, more positive trend for Aurora or if it really is in danger of going to zero and investors should jump ship.
The marijuana industry in general is doing well amid the pandemic. Does this beaten-down Canadian pot stock have any chance of rebounding?
The coronavirus disease 2019 (COVID-19) pandemic hasn't deterred consumers eager to buy cannabis products. In Canada, licensed cannabis store sales hit yet another all-time high in September ($197.5 million). Canadian licensed producer Aurora Cannabis (NYSE: ACB) should be a permanent fixture in this monthly column.